… targeting efficiency and specificity, it is an important realization in the development of future
ligand-conjugated … affect “nanoparticle in vivo behavior” and interactions with cells, we …

… aimed at targeting cells in the TME, discusses major obstacles and principles in the
design of ligands for drug targeting and provides an overview of homing peptides in ligand-targeted …

… The hydrodynamic particle size was determined by DLS, which … by particles in the
sample. TEM was employed to study the morphology as well as particle size of the ligand-conjugated …

… The pDNA(pEGFP)/HPOCP polyplexes showed high gene transfection efficiency in HCT
119 cell. In addition, siRNA/HPOCP polyplexes formed spherical shape and have particle sizes …

… to controls of nonspecifically engineered particles with adsorbed biomolecular … targeting
ligand conjugated to the nanomaterial surface is successfully recognized and bound by its target …

… Therefore, in the present study, we attempted to design an intestinal epithelium cell targeting
… (B) Particle size and zeta potential of micelles, T-NPs and FQS-NPs (mean ± SD, n = 3). (C) …

… at the single-particle level for ligand-conjugated liposomes by nFCM. (a) Schematic diagram
of the preparation and ligand quantification processes of ligand-conjugated liposomes. (b) …

… increase the particle diameter compared to non-targeted LCP… vitro anti-tumor activity of
CD siRNA delivered by LCP-FA-scFv NPs The target delivery capability of dual ligand-conjugated …

… HA, as a polysaccharide, has various molecular weights that have been demonstrated to
have significant effect on their targeting efficiency. Instead of conjugating HA on the particles …

… ligand-conjugated particle. Our goal was to develop a micro/nano particle-based delivery
system for adhesion to inflamed cells … depend on the particle material and targeted cell types, …